Healthcare Realty Trust Inc 8-K

What Happened

• Healthcare Realty Trust Incorporated (through subsidiary Healthcare Realty Holdings, L.P.) announced on May 7, 2026 the issuance of $700 million aggregate principal amount of 3.00% Exchangeable Senior Notes due January 15, 2032 (the “Notes”), including $100 million issued under the initial purchasers’ option. The Notes pay interest semi‑annually (Jan 15 and Jul 15), begin interest payments Jan 15, 2027, and are fully and unconditionally guaranteed by the Company on a senior, unsecured basis. The offering is governed by an indenture with U.S. Bank Trust Company, N.A. as trustee.

Key Details

• Principal and coupon: $700.0M issued (plus $100.0M option exercised), 3.00% annual interest, maturity Jan 15, 2032.
• Exchange terms: initial exchange rate 43.4660 shares per $1,000 principal (initial exchange price ≈ $23.01/share); up to 35,750,750 shares may be issued initially upon exchange (subject to anti‑dilution adjustments). Exchange rights limited before Oct 15, 2031; thereafter holders may exchange until just before maturity.
• Call and fundamental-change protections: issuer may redeem (subject to liquidity and share‑price tests) beginning Jan 22, 2030; holders have limited put rights on certain fundamental changes. Notes are senior unsecured (equal to other senior unsecured debt), effectively subordinated to secured debt and structurally subordinated to non‑issuer subsidiaries’ liabilities.
• Hedging and dilution mitigation: the Company entered capped call transactions to reduce potential dilution and offset certain cash payments; initial cap price ≈ $27.41/share (≈40% premium to last sale price of $19.58). Cost of the capped calls was about $28 million.
• Registration and additional interest: the Company agreed to file a resale registration statement for shares issuable on exchange (effectiveness target ~180 days); certain registration failures can trigger additional interest (0.25% p.a. for first 90 days of accrual, then 0.50% p.a.) and a possible 3% maturity premium in limited circumstances.

Why It Matters

• This transaction raises significant capital ($700M) while giving noteholders the potential to convert debt into equity, which could dilute existing shareholders (initially up to ~35.8M shares).
• The notes increase leverage but carry a relatively low fixed coupon (3.00%), and the capped‑call hedges limit some dilution risk at a defined cap price (but cost the company ~$28M).
• Investors should watch for potential dilution if exchanges occur, monitor the Company’s debt metrics and liquidity given the new senior unsecured obligation, and follow the resale registration progress (delays can trigger additional interest or premiums).